KGLAX
Price
$17.06
Change
-$0.02 (-0.12%)
Updated
Sep 5 closing price
Net Assets
66.38M
RLBCX
Price
$37.73
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

KGLAX vs RLBCX

Header iconKGLAX vs RLBCX Comparison
Open Charts KGLAX vs RLBCXBanner chart's image
Kinetics Global Adv A
Price$17.06
Change-$0.02 (-0.12%)
VolumeN/A
Net Assets66.38M
American Funds American Balanced R3
Price$37.73
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
KGLAX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KGLAX vs. RLBCX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KGLAX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 258B vs. KGLAX (66.4M). RLBCX pays higher dividends than KGLAX: RLBCX (1.53) vs KGLAX (0.70). KGLAX was incepted earlier than RLBCX: KGLAX (17 years) vs RLBCX (23 years). KGLAX (2.29) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. KGLAX (34.00). RLBCX has a lower initial minimum investment than KGLAX: RLBCX (250) vs KGLAX (2500). KGLAX annual gain was more profitable for investors over the last year : 39.10 vs. RLBCX (9.58). KGLAX return over 5 years is better than : 175.64 vs. RLBCX (37.90).
KGLAXRLBCXKGLAX / RLBCX
Total Expense Ratio1.640.89184%
Annual Report Gross Expense Ratio2.290.89257%
Fund Existence17 years23 years-
Gain YTD7.42111.12767%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets66.4M258B0%
Annual Yield % from dividends0.701.5345%
Returns for 1 year39.109.58408%
Returns for 3 years110.7938.72286%
Returns for 5 years175.6437.90463%
Returns for 10 years268.9572.02373%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTKWY127.031.93
+1.54%
Wolters Kluwer N.V.
GNNSF2.20N/A
N/A
Genscript Biotech Corp
SPSTY7.52N/A
N/A
Singapore Post, Ltd.
KSTBF0.06N/A
N/A
Kestrel Gold, Inc.
HPURF0.20N/A
N/A
HEXAGON PURUS ASA